Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 37
Filter
1.
Journal of Peking University(Health Sciences) ; (6): 843-850, 2023.
Article in Chinese | WPRIM | ID: wpr-1010139

ABSTRACT

OBJECTIVE@#To investigate the imaging effect of a near-infrared fluorescent targeted probe ICG-NP41 on the neurovascular bundles (NVB) around the prostate in rats.@*METHODS@#A near-infrared fluorescent targeted probe ICG-NP41 was synthesized. An animal model for NVB imaging was established using Sprague-Dawley rats (250-400 g). Experiments were conducted using a custom-built near-infrared windowⅡ(NIR-Ⅱ) small animal in vivo imaging system, and images collected were processed using ImageJ and Origin. The fluorescence signal data were statistically analyzed using GraphPad Prism. The signal-to-background ratio (SBR) for NVB was quantitatively calculated to explore the effective dosage and imaging time points. Finally, paraffin pathology sections and HE staining were performed on the imaging structures.@*RESULTS@#Except for rats in the control group (n=2), right-sided NVB of the rats injected with ICG-NP41 (n=2 per group) were all observed in NIR-Ⅱ fluorescence mode 2 h and 4 h after administration. At 2 h and 4 h, average SBR of cavernous nerve in 2 mg/kg group in fluorescence mode was 1.651±0.142 and 1.619±0.110, respectively, both higher than that in white light mode (1.111±0.036), with no significant difference (P>0.05); average SBR of 4 mg/kg group in fluorescence mode were 1.168±0.066 and 1.219±0.118, respectively, both higher than that in white light mode (1.081±0.040), with no significant difference (P>0.05). At 2 h and 4 h, the average SBR of 2 mg/kg and 4 mg/kg groups in fluorescence mode were higher than that of the control group (SBR=1), the average SBR of the 2 mg/kg group was higher than that of the 4 mg/kg group, and all the above with no significant difference (P>0.05). The average diameter of the nerve measured by full width at half maxima method was about (178±15) μm. HE staining of paraffin sections showed the right major pelvic ganglion.@*CONCLUSION@#The near-infrared fluorescent targeted probe ICG-NP41 can be used for real-time imaging of the NVB around the prostate in rats, providing a potential feasible solution for localizing NVB in real time during nerve-sparing radical prostatectomy.


Subject(s)
Male , Rats , Animals , Prostate/diagnostic imaging , Paraffin , Indocyanine Green , Rats, Sprague-Dawley , Fluorescent Dyes
2.
Journal of Peking University(Health Sciences) ; (6): 812-817, 2023.
Article in Chinese | WPRIM | ID: wpr-1010134

ABSTRACT

OBJECTIVE@#To investigate the diagnostic efficacy of targeted biopsy (TBx), systematic biopsy (SBx), TBx+6-core SBx in prostate cancer (PCa) / clinically significant prostate cancer (cs-PCa) for patients with prostate imaging reporting and data system (PI-RADS) score of 5, and thereby to explore an optimal sampling scheme.@*METHODS@#The data of 585 patients who underwent multiparametric magnetic resonance imaging (mpMRI) with at least one lesion of PI-RADS score 5 at Peking University First Hospital from January 2019 to June 2022 were retrospectively analyzed. All patients underwent mpMRI / transrectal ultrasound (TRUS) cognitive guided biopsy (TBx+SBx). With the pathological results of combined biopsy as the gold standard, we compared the diagnostic efficacy of TBx only, SBx only, and TBx+6-core SBx for PCa/csPCa. The patients were grouped according to mpMRI T-stage (cT2, cT3, cT4) and the detection rates of different biopsy schemes for PCa/csPCa were compared using Cochran's Q and McNemar tests.@*RESULTS@#Among 585 patients with a PI-RADS score of 5, 560 (95.7%) were positive and 25(4.3%) were negative via TBx+SBx. After stratified according to mpMRI T-stage, 233 patients (39.8%) were found in cT2 stage, 214 patients (36.6%) in cT3 stage, and 138 patients (23.6%) in cT4 stage. There was no statistically significant difference in the detection rate of PCa/csPCa between TBx+6-core SBx and TBx+SBx (all P>0.999). Also, there was no statistically significant difference in the detection rate of PCa/csPCa between TBx and TBx+SBx in the cT2, cT3, and cT4 subgroups (PCa: P=0.203, P=0.250, P>0.999; csPCa: P=0.700, P=0.250, P>0.999). The missed diagnosis rate of SBx for PCa and csPCa was 2.1% (12/560) and 1.8% (10/549), and that of TBx for PCa and csPCa was 1.8% (10/560) and 1.4% (8/549), respectively. However, the detection rate of TBx+6-core SBx for PCa and csPCa was 100%. Compared with TBx+SBx, TBx and TBx+6-core SBx had a fewer number of cores and a higher detection rate per core (P < 0.001).@*CONCLUSION@#For patients with a PI-RADS score of 5, TBx and TBx+6-core SBx showed the same PCa/csPCa detection rates and a high detection rates per core as that of TBx+SBx, which can be considered as an optimal scheme for prostate biopsy.


Subject(s)
Male , Humans , Prostatic Neoplasms/pathology , Magnetic Resonance Imaging/methods , Retrospective Studies , Prostate/diagnostic imaging , Image-Guided Biopsy/methods
3.
Asian Journal of Andrology ; (6): 361-365, 2023.
Article in English | WPRIM | ID: wpr-981938

ABSTRACT

This study evaluated the association of periurethral calcification (PUC) with uroflowmetric parameters and symptom severity in male patients with lower urinary tract symptoms (LUTS) of benign prostatic hyperplasia (BPH). The data were collected from a prospectively maintained database of 1321 men with LUTS of BPH who visited Chonnam National University Hospital (Gwang-ju, Korea) from January 2015 to December 2019. PUC severity and location were evaluated on the midsagittal plane during transrectal ultrasonography. Relationships among age, prostate-related parameters, International Prostate Symptom Score (IPSS), and uroflowmetric parameters were assessed. Among the 1321 patients in this study, 530 (40.1%) had PUC. Patients with PUC had significantly higher IPSS (mean ± standard deviation [s.d.]: 15.1 ± 8.7 vs 13.1 ± 7.9; P < 0.001) and lower peak flow rate (Qmax; mean ± s.d.: 12.4 ± 6.6 ml s-1 vs 14.7 ± 13.3 ml s-1; P < 0.001), compared with patients who did not have PUC. Analyses according to PUC severity revealed that patients with severe PUC had higher prostate-specific antigen (PSA) level (P = 0.009), higher total IPSS (P < 0.001), lower Qmax (P = 0.002), and smaller prostate volume (P < 0.001), compared with patients who had non-severe (mild or moderate) PUC. Multivariate analysis showed that distal PUC was independently associated with high total IPSS (P = 0.02), voiding symptom score (P = 0.04), and storage symptom score (P = 0.023), and low Qmax (P = 0.015). In conclusion, PUC was significantly associated with worse LUTS parameters in terms of IPSS and Qmax. Furthermore, distally located PUC was independently associated with worse LUTS of BPH in men.


Subject(s)
Humans , Male , Prostatic Hyperplasia/diagnostic imaging , Prostate/diagnostic imaging , Clinical Relevance , Hyperplasia , Lower Urinary Tract Symptoms/complications , Calcinosis/diagnostic imaging
4.
Journal of Biomedical Engineering ; (6): 226-233, 2023.
Article in Chinese | WPRIM | ID: wpr-981533

ABSTRACT

Magnetic resonance (MR) imaging is an important tool for prostate cancer diagnosis, and accurate segmentation of MR prostate regions by computer-aided diagnostic techniques is important for the diagnosis of prostate cancer. In this paper, we propose an improved end-to-end three-dimensional image segmentation network using a deep learning approach to the traditional V-Net network (V-Net) network in order to provide more accurate image segmentation results. Firstly, we fused the soft attention mechanism into the traditional V-Net's jump connection, and combined short jump connection and small convolutional kernel to further improve the network segmentation accuracy. Then the prostate region was segmented using the Prostate MR Image Segmentation 2012 (PROMISE 12) challenge dataset, and the model was evaluated using the dice similarity coefficient (DSC) and Hausdorff distance (HD). The DSC and HD values of the segmented model could reach 0.903 and 3.912 mm, respectively. The experimental results show that the algorithm in this paper can provide more accurate three-dimensional segmentation results, which can accurately and efficiently segment prostate MR images and provide a reliable basis for clinical diagnosis and treatment.


Subject(s)
Male , Humans , Prostate/diagnostic imaging , Image Processing, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Imaging, Three-Dimensional/methods , Prostatic Neoplasms/diagnostic imaging
5.
Lima; IETSI; mayo 1, 2021. 109 p. tab, ilus.
Non-conventional in Spanish | BIGG, LILACS | ID: biblio-1363277

ABSTRACT

El cáncer de próstata es producto de una proliferación descontrolada de células glandulares, ductales u otras de la glándula prostática. El tipo histológico más frecuente es el adenocarcinoma y se ubican principalmente en la zona periférica de la próstata (1). Así mismo, esta neoplasia se puede clasificar según el estadio clínico en cáncer de próstata localizado, localmente avanzado, y metastásico. Además, el cáncer de próstata localizado puede clasificarse según el riesgo en riesgo bajo, intermedio, o alto (1-4). En el mundo, el cáncer de próstata es la segunda neoplasia maligna más frecuente y una de las principales causas de mortalidad por cáncer en varones. Se diagnostican más de 1,2 millones de casos y las muertes relacionadas a esta neoplasia suelen superar las 350 mil cada año (1). En Perú, se reportó que el cáncer de próstata fue la neoplasia maligna más frecuente y la segunda más letal, independientemente de la edad y género (44,3 casos nuevos por cada 1000 habitantes, y 11,4 fallecimientos por cada 1000 habitantes, respectivamente) en el 2020, tendencia que se mantiene si se toma en cuenta solo a varones (5). En adición, en el Seguro Social de Salud de Perú (EsSalud) se estimó que el cáncer de próstata representó el 3,8% de los años de vida perdidos por muerte prematura causados por tumores malignos en el 2018 (6). Para reducir las cifras de mortalidad causadas por cáncer de próstata y otras neoplasias, en 2012 se implementó el Plan Esperanza, el cual pretende cubrir los servicios de prevención, detección temprana, diagnóstico definitivo, estadiaje, tratamiento y cuidado paliativo (7). Pese a ello, la tendencia de mortalidad por cáncer de próstata en varones mayores de 50 años se ha incrementado entre los años 2009 y 2016 (10,9% vs 21,8%, respectivamente) (8). Además, el manejo del cáncer de próstata se ha vuelto más complejo con el advenimiento de nuevas formas de subclasificación de grupos de riesgo, y nueva evidencia sobre la eficacia y seguridad de las diferentes modalidades de tratamiento inicial para esta neoplasia (3, 4, 9). Por ello, el Seguro Social de Salud (EsSalud) priorizó la realización de la presente guía de práctica clínica (GPC) para establecer enunciados basados en evidencia con el fin de gestionar de la mejor manera los procesos y procedimientos asistenciales de la presente condición. Esta GPC fue realizada por la Dirección de Guías de Práctica Clínica, Farmacovigilancia y Tecnovigilancia del Instituto de Evaluación de Tecnologías en Salud e Investigación (IETSI) de EsSalud.


Subject(s)
Humans , Male , Prostate/diagnostic imaging , Prostatic Neoplasms , Prostate/pathology , Ultrasonography
6.
Revista Digital de Postgrado ; 10(1): 262, abr. 2021. tab
Article in Spanish | LIVECS, LILACS | ID: biblio-1147578

ABSTRACT

El bloqueo del nervio peri prostático con lidocaína, proporciona un buen alivio del dolor en la realización de la biopsia prostática guiada por ultrasonido, pero el dolor post-procedimiento, puede llegar a ser significativo, la adición del supositorio de diclofenac, podría proporcionar alivio adicional. Se asignaron al azar pacientes en 2 grupos el grupo 1 bloqueo con lidocaína del plexo peri prostático + supositorio de diclofenac sódico y el grupo 2 bloqueo con lidocaína del plexo peri prostático + supositorio de placebo, realizando biopsia doble sextante, el dolor a varios intervalos después del procedimiento se registró en una escala visual análoga (EVA) de 0 a 10. Los 2 grupos fueron similares en cuanto a edad, volumen de próstata, antígeno prostático específico, diagnóstico histopatológico. Los pacientes que recibieron diclofenac tuvieron puntajes de dolor significativamente más bajos que los que recibieron placebo (2 frente a 3,35) p 0,02. La administración rectal de diclofenac antes de la realización de la biopsia de próstata es un procedimiento simple que alivia significativamente el dolor experimentado sin aumento en la morbilidad(AU)


The peri-prostatic nerve block with lidocaine, provides good pain relief in performing ultrasoundguided prostate biopsy, but the postprocedure pain can be significant, the addition of diclofenac suppository, could provide additional relief. Patients were randomly assigned in 2 groups to group 1 blockade with lidocaine of the prostatic peri plexus + suppository of diclofenac sodium and group 2 blockade with lidocaine of the prostatic peri plexus + placebo suppository, performing double sextant biopsy, pain at several intervals after the procedure was recorded on a visual analog scale (EVA) from 0 to 10. Thee 2 groups were similar in terms of age, prostate volume, prostate-specific antigen, histopathological diagnosis. Patients who received diclofenac had pain scores significantly lower than those who received placebo (2 vs. 3.35) p 0.02. Rectal administration of diclofenac before performing a prostate biopsy is a simple procedure that relieves significantly pain experienced without increased morbidity(AU)


Subject(s)
Humans , Male , Middle Aged , Aged , Aged, 80 and over , Prostate/pathology , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Diclofenac/therapeutic use , Anesthetics, Local/therapeutic use , Lidocaine/therapeutic use , Nerve Block/methods , Placebos/therapeutic use , Prostate/diagnostic imaging , Administration, Rectal , Prospective Studies , Pain Management/methods , Image-Guided Biopsy , Anesthesia, Local
7.
Arq. bras. med. vet. zootec. (Online) ; 72(6): 2135-2140, Nov.-Dec. 2020. tab, ilus
Article in English | VETINDEX, LILACS | ID: biblio-1142306

ABSTRACT

The aim of this study was to assess the applicability of ARFI elastography for the complementary diagnosis of canine prostatic alterations. Twenty-two healthy dogs and 45 with prostatic alterations were diagnosed by the association of general and specific physical exams. Complete blood count, B-mode and Doppler ultrasound were performed. For the elastography study, tissue homogeneity and deformity were verified using the elastogram, and the shear velocities of the left and right lobes of all prostates were obtained. The change in tissue homogeneity was observed in 62.2% of the animals, while the shear speed was significantly higher in dogs with prostatic alterations, with a cut-off point > 2.35m/s as an indication of change. All animals in both groups were non-deformable. It was concluded that ARFI elastography is capable of providing qualitative and quantitative results that assist in the diagnosis of canine prostatic alterations in a non-invasive way.(AU)


O objetivo deste estudo foi avaliar a aplicabilidade da elastografia ARFI na complementação diagnóstica das alterações prostáticas em cães. Foram avaliados 22 cães saudáveis e 45 com alterações prostáticas, diagnosticadas pela associação de exames físicos geral e específico, hemograma, ultrassonografia modo B e Doppler. No estudo elastográfico, foram verificadas a homogeneidade e a deformidade tecidual, pelo elastograma, e obtidas as velocidades de cisalhamento dos lobos esquerdo e direito de todas as próstatas. A alteração de homogeneidade tecidual foi observada em 62,2% dos animais, enquanto a velocidade de cisalhamento se mostrou significativamente maior em cães com alterações prostáticas, com ponto de corte >2,35m/s como indicativo de alteração. Todos os animais de ambos os grupos se apresentaram não deformáveis. Concluiu-se que a elastografia ARFI é capaz de fornecer resultados qualitativos e quantitativos que auxiliam no diagnóstico das alterações prostáticas caninas de forma não invasiva.(AU)


Subject(s)
Animals , Dogs , Prostate/diagnostic imaging , Elasticity Imaging Techniques/veterinary , Ultrasonography, Doppler/veterinary
8.
Einstein (Säo Paulo) ; 18: eAO4662, 2020. tab, graf
Article in English | LILACS | ID: biblio-1056076

ABSTRACT

ABSTRACT Objective To assess accuracy of multiparametric magnetic resonance of the prostate to estimate gland volume, comparing the results with transrectal ultrasound and surgical specimen. Methods A retrospective study of 85 patients who underwent multiparametric magnetic resonance and transrectal ultrasound (for fusion image-guided biopsy) before radical prostatectomy. Prostate measurements were obtained from magnetic resonance axial and sagittal T2-weighted images and ultrasound; the prostate volume was determined using the ellipsoid formula. The results were compared with the surgical specimen weight. Maximum interval between multiparametric magnetic resonance imaging, transrectal ultrasound, and prostatectomy was 6 months. Results The prostate volume measured by multiparametric magnetic resonance imaging was 18-157cm3 (mean of 49.9cm3) and by transrectal ultrasound, 22-165cm3 (mean of 54.9cm3); the surgical specimen weight was 20-154g (mean of 48.6g), with no statistical differences. Based on the values obtained from imaging examinations, the prostate volume obtained was very close to the real prostatic weight, and the measures by multiparametric magnetic resonance were slightly more precise. Conclusion Prostate volume measured by multiparametric magnetic resonance imaging and transrectal ultrasound showed similar values, and excellent agreement with real prostate weight of the surgical specimens. Prostate volume measured by magnetic resonance has been increasingly used in the clinical practice, and its value enables appropriate therapeutic planning and control of patients.


RESUMO Objetivo Avaliar a acurácia da ressonância magnética multiparamétrica da próstata para estimativa do volume da glândula, comparando seus resultados com a ultrassonografia transretal e correlacionando com o volume obtido da peça cirúrgica. Métodos Estudo retrospectivo incluindo 85 pacientes submetidos à ressonância magnética e, posteriormente, à ultrassonografia transretal (para orientação de biópsia com fusão de imagens) e, a seguir, à prostatectomia radical. As dimensões prostáticas foram obtidas na ressonância a partir das imagens nos planos axial e sagital em sequências ponderadas em T2 e, assim como na ultrassonografia, o volume foi calculado a partir do método da elipsoide. Os valores foram comparados com o peso prostático pós-cirúrgico. O intervalo máximo entre a ressonância e ultrassonografia e prostatectomia foi de 6 meses. Resultados O volume prostático obtido por ressonância magnética foi de 18 a 157cm3(média de 49,9cm3); pela ultrassonografia transretal, foi de 22 a 165cm3(média de 54,9cm3); e o peso da peça cirúrgica foi de 20 a 154g (média de 48,6g), sem diferenças estatísticas. A partir do valor obtido por esses métodos de imagem, provou-se que o volume prostático obtido aproximou-se bastante do peso real da próstata, com discreta maior precisão das medidas obtidas por ressonância magnética multiparamétrica. Conclusão As medidas do volume prostático adquiridas pela ressonância magnética e pela ultrassonografia transretal são semelhantes entre si, com excelente concordância com os pesos reais das próstatas obtidos das peças cirúrgicas. A avaliação desse dado, a partir da ressonância, método cada vez mais utilizado na prática clínica, permite o adequado planejamento terapêutico e o controle dos pacientes.


Subject(s)
Humans , Male , Adult , Aged , Aged, 80 and over , Prostate/anatomy & histology , Prostatic Neoplasms/diagnostic imaging , Ultrasonography/methods , Multiparametric Magnetic Resonance Imaging/methods , Organ Size , Prostate/diagnostic imaging , Prostatectomy , Prostatic Neoplasms/pathology , Retrospective Studies , Image-Guided Biopsy/methods , Dimensional Measurement Accuracy , Middle Aged
9.
Rev. chil. radiol ; 25(4): 128-140, dic. 2019. tab, ilus
Article in Spanish | LILACS | ID: biblio-1058213

ABSTRACT

Resumen: La resonancia magnética multiparamétrica (RMmp) de próstata ha tenido un desarrollo importante en los últimos años dado la alta prevalencia del cáncer de próstata y la necesidad de tener información imagenológica concreta para el correcto manejo de los pacientes urológicos. Otras técnicas de imágenes aportan información parcial sobre la morfología de la próstata, pero es la RMmp de próstata la técnica imagenológica que nos entrega mayor información, a través de secuencias morfológicas y funcionales, para detectar lesiones clínicamente significativas y disminuir el número de biopsias, predecir riesgo de agresividad de los tumores, estadificación local y ayudar al urólogo a realizar biopsias dirigidas cognitivas o por fusión RM/US. En este artículo se pretende mostrar casos representativos de errores frecuentes al momento de informar una resonancia magnética de próstata. Damos algunas recomendaciones para evitar estos errores y mejorar los informes radiológicos. Es común al comenzar a realizar informes de RMmp de próstata tener dudas sobre la correcta interpretación de los hallazgos. Ofrecemos a través de este articulo imágenes representativas de los principales errores en la búsqueda de patología neoplásica y algunas sugerencias para evitarlos. Desde el punto de vista académico se pueden dividir en pitfalls de condiciones anatómicas y patologías benignas que pueden simular un tumor. En el caso de pitfalls anatómicos mostramos casos referentes al estroma fibromuscular anterior hipertrófico, cápsula quirúrgica engrosada, plexo venoso peri-prostático, complejo neurovascular y pseudolesión posterior en zona periférica. Dentro de las condiciones benignas se encuentra la hiperplasia prostática benigna, procesos inflamatorios/infecciosos y otras condiciones que pueden simular tumor. Respecto a pitfalls relacionados con la hiperplasia prostática benigna podemos señalar hiperplasia de la zona de transición / central ("moustache-sign"), proliferación estromal en la zona de transición y nódulos adenomatosos ectópicos u extruidos en la zona periférica (ZP). Pitfalls inflamatorios/infecciosos corresponden a casos de prostatitis focal, prostatitis aguda, prostatitis con abscesos y prostatitis granulomatosa. Otros errores frecuentes de dificultad en la interpretación corresponden a casos de calcificaciones y hemorragia.


Abstract: Multiparameter magnetic resonance imaging (RMmp) of the prostate has had an important development in recent years given the high prevalence of prostate cancer and the need to have specific imaging information for the correct management of urological patients. Other imaging techniques provide partial information about the morphology of the prostate, but it is the mp-MRI of the prostate that gives us more information, through morphological and functional sequences, to detect clinically significant lesions and reduce the number of biopsies, predict risk of aggressiveness of the tumors, local staging and help the urologist to perform cognitive biopsies or by MR / US fusion. This article aims to show representative cases of frequent errors when reporting an MRI of the prostate. We give some recommendations to avoid these errors and improve radiological reports. It is common to start making mp-MRI of the prostate reports having doubts about the correct interpretation of the findings. We offer through this article representative images of the main errors in the search for neoplastic pathology and some suggestions to avoid them. From the academic point of view they can be divided into pitfalls of anatomical conditions and benign pathologies that can simulate a tumor. In the case of anatomical pitfalls, we show cases related to the hypertrophic anterior fibromuscular stroma, thickened surgical capsule, peri-prostatic venous plexus, neurovascular complex and posterior pseudo-injury in the peripheral area. Among the benign conditions is benign prostatic hyperplasia, inflammatory / infectious processes and other conditions that can simulate tumor. Regarding pitfalls related to benign prostatic hyperplasia, we can indicate hyperplasia of the transition / central zone ("mustache-sign"), stromal proliferation in the transition zone and ectopic or extruded adenomatous nodules in the peripheral zone. Inflammatory / infectious pitfalls correspond to cases of focal prostatitis, acute prostatitis, prostatitis with abscesses and granulomatous prostatitis. Other frequent errors of difficulty in interpretation correspond to cases of calcifications and hemorrhage.


Subject(s)
Humans , Prostate/diagnostic imaging , Prostatic Neoplasms/diagnostic imaging , Diagnostic Errors , Multiparametric Magnetic Resonance Imaging , Prostate/pathology , Prostatic Neoplasms/pathology , Diffusion Magnetic Resonance Imaging
10.
Int. braz. j. urol ; 45(3): 486-494, May-June 2019. tab, graf
Article in English | LILACS | ID: biblio-1012318

ABSTRACT

ABSTRACT Objectives: To identify the group of patients who could safely avoid prostate biopsy based on the findings of multiparametric prostate resonance imaging (MRmp), parameterized with PI-RADS v2, using prostate biopsy as reference test and to assess the sensitivity and specificity of mpMR in identifying clinically significant prostate cancer using prostate biopsy as a reference test. Patients and Methods: Three hundred and forty two patients with suspected prostate cancer were evaluated with mpMR and prostate biopsy. Agreement between imaging findings and histopathological findings was assessed using the Kappa index. The accuracy of mpMR in relation to biopsy was assessed by calculations of sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). Results: A total of 342 biopsies were performed. In 201 (61.4%), mpMR had a negative result for cancer, which was confirmed on biopsy in 182 (53%) of the cases, 17 (4.9%) presented non-clinically significant cancer and only 2 (0.5%) clinically significant cancer. 131 (38.3%) patients had a positive biopsy. Clinically significant cancer corresponded to 83 (34.2%), of which 81 (97.5%) had a positive result in mpMR. Considering only the clinically significant cancers the mpMR had a sensitivity of 97.6%, specificity of 76.8%, PPV 57.4% and VPN of 99%. Conclusions: mpMR is a useful tool to safely identify which patients at risk for prostate cancer need to undergo biopsy and has high sensitivity and specificity in identifying clinically significant prostate cancer.


Subject(s)
Humans , Male , Female , Adult , Aged , Aged, 80 and over , Prostate/pathology , Prostate/diagnostic imaging , Prostatic Neoplasms/pathology , Prostatic Neoplasms/diagnostic imaging , Magnetic Resonance Imaging/methods , Image-Guided Biopsy/methods , Reference Standards , Reproducibility of Results , Retrospective Studies , Risk Factors , Sensitivity and Specificity , Neoplasm Grading , Middle Aged
11.
Asian Journal of Andrology ; (6): 177-182, 2019.
Article in English | WPRIM | ID: wpr-1009665

ABSTRACT

We aimed to evaluate the feasibility of simultaneous image acquisition of multiple instantaneous switchable scan (MISS) for prostate magnetic resonance imaging (MRI) on 3T. Fifty-three patients were scanned with MRI due to suspected prostate cancer. Twenty-eight of them got histological results. First, two readers assessed the structure delineation and image quality based on images of conventional T2-weighted imaging (T2WI) and diffusion-weighted imaging (DWI) (CTD). Second, two readers identified the index lesion together, and then, reader one evaluated the contrast of index lesion on T2WI and signal ratio on apparent diffusion coefficient map. Third, they assigned Prostate Imaging Reporting and Data System (PI-RADS) score in consensus for the index lesion. After 4 weeks, the images of MISS were reviewed by the same readers following the same process. Finally, two readers gave preference for image interpretation, respectively. Kappa coefficient, Wilcoxon signed-rank test, paired-sample t-test, Bland-Altman analysis, and receiver operating characteristic (ROC) analysis were used for statistical analysis. The acquisition time of CTD was 6 min and 10 s, while the acquisition time of MISS was 4 min and 30 s. Interobserver agreements for image evaluation were κ = 0.65 and κ = 0.80 for CTD and MISS, respectively. MISS-T2WI showed better delineation for seminal vesicles than CTD-T2WI (reader 1: P < 0.001, reader 2: P = 0.001). The index lesion demonstrated higher contrast in MISS-T2WI (P < 0.001). The PI-RADS scores based on CTD and MISS exhibited high ability in predicting clinically significant cancer (area under curve [AUC] = 0.828 vs 0.854). Readers preferred to use MISS in 41.5%-47.2% of cases. MISS showed comparable performance to conventional technique with less acquisition time.


Subject(s)
Adult , Aged , Aged, 80 and over , Humans , Male , Middle Aged , Young Adult , Diffusion Magnetic Resonance Imaging/methods , Image Processing, Computer-Assisted/methods , Magnetic Resonance Imaging/methods , Prostate/diagnostic imaging , Prostatic Neoplasms/diagnostic imaging , Seminal Vesicles/diagnostic imaging
12.
Univ. med ; 60(2): 1-7, 2019. ilus, tab
Article in Spanish | LILACS, COLNAL | ID: biblio-994580

ABSTRACT

El absceso prostático es una entidad urológica con poca evidencia estadísticamente significativa y pocos estudios que permitan realizar una guía de manejo estandarizada. Se define como la presencia de una o varias colecciones purulentas en la próstata (1), que con un diagnóstico temprano y adecuado manejo médico y/o quirúrgico, tiene una baja morbimortalidad. La presente revisión de tema, reúne los estudios más recientes y sobresalientes en el diagnóstico y manejo de esta patología, de modo que en un futuro se pueda estandarizar el manejo entre los especialistas en esta área.


Prostatic abscess is an urological entity with few statistical significant evidence that allows us to stablish a standardized management guide. It is defined as one or multiple supurative collections in the prostate, which has a low morbidity and mortality with early diagnosis and appropriate management. The next review, group the most important and recent studies in this pathology, so that in the future we could stablish a standardized managent among tthe urologists.


Subject(s)
Humans , Abscess , Prostate/diagnostic imaging , Ultrasonics
13.
Int. braz. j. urol ; 44(2): 238-247, Mar.-Apr. 2018. tab, graf
Article in English | LILACS | ID: biblio-892970

ABSTRACT

ABSTRACT Introduction and objective To determine the association between the anthropometric measurements by magnetic resonance imaging (MRI) and perioperative outcomes of extraperitoneal laparoscopic radical prostatectomy (ELRP). Materials and Methods From 2008 to June 2016, 86 patients underwent preoperative MRI prior to undergoing ELRP for localized prostate cancer. We analyzed the associations between anthropometric measurements of MRI and the perioperative outcomes of patients who underwent ELRP. Results The mean patient age was 69.61±8.30 years. The medians of operating time and blood loss were 2.30 hours and 725.30ml, respectively. The total post-surgical complication rate was 1.16%. The median hospital stay was 6.50 days. The pathological stages for T2 and T3 were 45.74% and 34.04%, respectively. The rate as positive surgical margins (PSMs) was 18.09% (pT2 and pT3; 6.38% and 9.57%). The angles between pubic bone and prostate gland (angle 1&2), were significantly associated with operative time and hospital stay, respectively (p<0.05). There was no correlation between the pelvimetry and positive surgical margin. Conclusions The findings of the present study suggest that anthropometric measurements of the MRI are related to operative difficulties in ELRP. This study confirmed that MRI planning is the key to preventing complications in ELRP.


Subject(s)
Humans , Male , Aged , Prostate/diagnostic imaging , Prostatectomy/methods , Prostatic Neoplasms/surgery , Prostatic Neoplasms/diagnostic imaging , Laparoscopy/methods , Organ Size , Postoperative Complications/prevention & control , Prostate/pathology , Prostatectomy/adverse effects , Prostatic Neoplasms/pathology , Body Composition , Magnetic Resonance Imaging , Blood Loss, Surgical , Treatment Outcome , Laparoscopy/adverse effects , Operative Time , Middle Aged
14.
Asian Journal of Andrology ; (6): 581-586, 2018.
Article in English | WPRIM | ID: wpr-1009633

ABSTRACT

Traditional laparoscopic radical prostatectomy is a treatment choice in many developing countries and regions for most patients with localized prostate cancer; however, no system for predicting surgical difficulty and risk has been established. This study aimed to propose a simple and standard preoperative classification system of prostate cancer using preoperative data to predict surgical difficulty and risk and to evaluate the relationship between the data and postoperative complications. We collected data from 236 patients and divided them into three groups to evaluate and validate the relationships among preoperative, operative, and postoperative data. This new scoring system is based on the body mass index, ultrasonic prostate volume, preoperative prostate-specific antigen level, middle lobe protrusion, and clinical stage. In the scoring group, we classified 89 patients into two groups: the low-risk group (score of <4) and high-risk group (score of ≥4), and then compared the postoperative data between the two groups. The positive surgical margin rate was higher in the high-risk group than low-risk group. The results in validation Groups A and B were similar to those in the scoring group. The focus of our scoring system is to allow for preliminary assessment of surgical difficulty by collecting the patients' basic information. Urologists can easily use the scoring system to evaluate the surgical difficulty and predict the risks of a positive surgical margin and urinary incontinence in patients undergoing laparoscopic radical prostatectomy.


Subject(s)
Humans , Male , Body Mass Index , Laparoscopy , Neoplasm Staging , Postoperative Complications/epidemiology , Predictive Value of Tests , Preoperative Period , Prostate/diagnostic imaging , Prostate-Specific Antigen/analysis , Prostatectomy/statistics & numerical data , Prostatic Neoplasms/surgery , Risk Assessment , Ultrasonography
15.
Asian Journal of Andrology ; (6): 69-74, 2018.
Article in English | WPRIM | ID: wpr-1009528

ABSTRACT

This study aimed to investigate perceived ejaculatory function/satisfaction before treatment for lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) and to identify associations between specific categories of ejaculatory dysfunctions (EjDs) and LUTS. A total of 1574 treatment-naïve men with LUTS/BPH were included in this study. All patients underwent routine evaluation for LUTS/BPH including the International Index of Erectile Function and a 5-item questionnaire developed to assess ejaculatory volume/force/pain/satisfaction/latency time. Patients who had sexual intercourse over the past 4 weeks were classified as sexually active group. A total of 783 patients were categorized as sexually active group. Decreased ejaculatory volume and force were reported by 53.4% and 55.7% of 783 sexually active men, respectively. There was a strong correlation between ejaculatory volume and force. Ejaculatory pain/discomfort, premature ejaculation (PE), and delayed ejaculation (DE) were reported in 41.0%, 16.3%, and 41.4% of the patients, respectively. Over 40.0% of men without decreased ejaculation volume/force were satisfied with ejaculatory function, whereas approximately 6.0% of men with decreased volume/force were satisfied with ejaculatory function. About 30.0% of men with decreased volume/force had orgasmic dysfunction, while approximately 10.0% of men without decreased volume/force did. Decreased ejaculatory volume or force was associated with LUTS severity after adjusting for other influential factors including testosterone level, erectile function, and prostate size on ultrasonography, but PE or DE or ejaculatory pain/discomfort was not. In conclusion, a considerable portion of men with LUTS/BPH appear to have a variety of EjDs. Ejaculatory volume/force and satisfaction/orgasm do not always appear to be concordant. Ejaculatory volume or force is independently associated with LUTS severity, whereas PE or DE or ejaculatory pain/discomfort is not.


Subject(s)
Aged , Humans , Male , Middle Aged , Coitus , Ejaculation , Lower Urinary Tract Symptoms/physiopathology , Orgasm , Pain/etiology , Personal Satisfaction , Premature Ejaculation/physiopathology , Prostate/diagnostic imaging , Prostatic Hyperplasia/physiopathology , Sexual Dysfunction, Physiological/physiopathology , Surveys and Questionnaires , Testosterone/blood
16.
Rev. argent. urol. (1990) ; 83(3): 102-108, 2018. tab, ilus
Article in Spanish | LILACS | ID: biblio-986349

ABSTRACT

Objetivos: Analizar la performance diagnóstica de la punción biopsia prostática (PBP) guiada mediante ecografía con fusión de imágenes de resonancia magnética (RM) para la detección del cáncer de próstata (CP) en pacientes con biopsia previa negativa. Materiales y métodos: Se analizaron todas las PBP transrrectales dirigidas bajo ecografía con fusión de imágenes de RM en pacientes mayores de 40 años de edad con sospecha de CP y biopsia previa randomizada negativa efectuadas durante el período comprendido entre enero de 2015 y enero de 2018. Se calculó la sensibilidad, especificidad, valor predictivo positivo y negativo de dicho procedimiento. Resultados: De un total de 40 pacientes, 25 cumplieron los criterios de inclusión. La PBP transrrectal guiada bajo ecografía con fusión de imágenes de RM presentó una sensibilidad del 90% en la detección de CP clínicamente significativo (CPsig), mostrando una mejoría en la detección del 20% respecto de la biopsia randomizada. Conclusiones: La PBP transrrectal guiada con ecografía y fusión de imágenes de RM mejora la performance en la detección de CPsig en pacientes con biopsia previa negativa(AU)


Objective: To analyze the diagnostic performance of transrectal prostate US (ultrasonography) guided biopsy with magnetic resonance imaging (MRI) fusion in the detection of prostate cancer in patients with negative previous biopsy. Materials and methods: Between January 2015 to January 2018, transrectal prostate biopsies under US guided with MRI fusion were performed in patients older than 40 years with suspicion of prostate cancer and prior negative biopsy. Sensitivity, specificity, positive and negative predictive value of the procedure were analyzed. Results: Out of a total of 40 patients, 25 met the inclusion criteria. Transrectal prostate US guided biopsy with MRI fusion presented a sensitivity of 90%, showing an improvement of 20% in the clinically significant prostate cancer detection compared with randomized biopsy. Conclusions: Transrectal prostate US guided biopsy with MRI fusion showed high performance in the detection of significative prostate cancer in patients with negative previous biopsy(AU)


Subject(s)
Male , Adult , Middle Aged , Aged , Prostatic Neoplasms/diagnostic imaging , Magnetic Resonance Imaging/methods , Ultrasonography , Image-Guided Biopsy/instrumentation , Image-Guided Biopsy/methods , Prostate/diagnostic imaging , Prostatic Neoplasms/pathology , Rectum , Cross-Sectional Studies
17.
Int. braz. j. urol ; 43(1): 29-35, Jan.-Feb. 2017. tab, graf
Article in English | LILACS | ID: biblio-840796

ABSTRACT

ABSTRACT Objectives To evaluate the predictive value of TRIMprob test to detect prostate cancer (PCa) in patients referred to prostate biopsy (PB). Material and Methods Patients with PSA <10ng/mL and rectal exam without findings suggestive of prostate cancer were selected for TRIMprob evaluation. Exam was performed by a single operator through transperineal approach. Patients admitted for the study were submitted to TRIMprob and multiparametric magnetic resonance (mpMRI) and posteriorly to PB. Results In total, 77 patients were included. TRIMprob showed evidences of PCa in 25 (32.5%) and was negative in 52 patients (67.5%). The rate of detection of prostate cancer at biopsy was higher in patients with positive TRIMprob (16/25; 64.0%) than in patients with negative TRIMprob (11/52; 21.1%; p<0.001). Sensitivity, specificity, positive predictive value, negative predictive value and accuracy of TRIMprob were respectively 61.5%, 82.0%, 64.0%, 80.3% and 74.0%. ROC curve showed the following areas under the curve values for TRIMprob, mpMRI and combination of TRIMprob + mpMRI: 0.706; 0.662 and 0.741 respectively. At combined analysis, when both TRIMprob and mpMRI were negative for prostate cancer, accuracy was 96.3% or only 1 in 27 PB was positive (3.7%). Conclusions Trimprob had similar predictive value for PCa in patients submitted to PB as mpMRI. Combined TRIMprob and mpMRI showed higher accuracy than when performed singly.


Subject(s)
Humans , Male , Adult , Aged , Prostatic Neoplasms/diagnostic imaging , Magnetic Resonance Imaging/methods , Diagnostic Techniques, Urological/instrumentation , Prostate/pathology , Prostate/diagnostic imaging , Prostatic Neoplasms/pathology , Reference Values , Biopsy , Cross-Sectional Studies , Reproducibility of Results , Retrospective Studies , Sensitivity and Specificity , Prostate-Specific Antigen/blood , Age Distribution , Neoplasm Grading , Middle Aged
18.
Int. braz. j. urol ; 42(5): 897-905, Sept.-Oct. 2016. tab, graf
Article in English | LILACS | ID: lil-796878

ABSTRACT

ABSTRACT Objective: To evaluate the diagnostic efficacy of transrectal ultrasonography (US) biopsy with imaging fusion using multiparametric (mp) magnetic resonance imaging (MRI) in patients with suspicion of prostate cancer (PCa), with an emphasis on clinically significant tumors according to histological criteria. Materials and Methods: A total of 189 consecutive US/MRI fusion biopsies were performed obtaining systematic and guided samples of suspicious areas on mpMRI using a 3 Tesla magnet without endorectal coil. Clinical significance for prostate cancer was established based on Epstein criteria. Results: In our casuistic, the average Gleason score was 7 and the average PSA was 5.0ng/mL. Of the 189 patients that received US/MRI biopsies, 110 (58.2%) were positive for PCa. Of those cases, 88 (80%) were clinically significant, accounting for 46.6% of all patients. We divided the MRI findings into 5 Likert scales of probability of having clinically significant PCa. The positivity of US/MRI biopsy for clinically significant PCa was 0%, 17.6% 23.5%, 53.4% and 84.4% for Likert scores 1, 2, 3, 4 and 5, respectively. There was a statistically significant difference in terms of biopsy results between different levels of suspicion on mpMRI and also when biopsy results were divided into groups of clinically non-significant versus clinically significant between different levels of suspicion on mpMRI (p-value <0.05 in both analyzes). Conclusion: We found that there is a significant difference in cancer detection using US/MRI fusion biopsy between low-probability and intermediate/high probability Likert scores using mpMRI.


Subject(s)
Humans , Male , Prostatic Neoplasms/pathology , Prostatic Neoplasms/diagnostic imaging , Magnetic Resonance Imaging/methods , Image-Guided Biopsy/methods , Prostate/pathology , Prostate/diagnostic imaging , Magnetic Resonance Imaging/instrumentation , Predictive Value of Tests , Reproducibility of Results , Retrospective Studies , Prostate-Specific Antigen/blood , Ultrasonography, Interventional/methods , Statistics, Nonparametric , Neoplasm Grading , Middle Aged
19.
Int. braz. j. urol ; 42(4): 704-709, July-Aug. 2016. tab, graf
Article in English | LILACS | ID: lil-794675

ABSTRACT

ABSTRACT Introduction: Despite the well-known findings related to malignity in DRE such as nodule and induration, asymmetry of prostatic lobes, seen relatively, were investigated in a few studies as a predictor of prostate cancer so that there is no universally expected conclusion about asymmetry. We aimed to compare cancer detection rate of normal, asymmetric or suspicious findings in DRE by using biopsy results. Materials and Methods: Data of 1495 patients underwent prostate biopsy between 2006-2014 were searched retrospectively. Biopsy indications were abnormal DRE and or elevated PSA level(>4ng/mL). DRE findings were recorded as Group 1: Benign DRE, Group 2: Asymmetry and Group 3: Nodule/induration. Age, prostatic volume, biopsy results and PSA levels were recorded. Results: Mean age, prostate volume and PSA level were 66.72, 55.98 cc and 18.61ng/ mL respectively. Overall cancer detection rate was 38.66 % (575 of 1495). PSA levels were similar in group 1 and 2 but significantly higher in group 3. Prostatic volume was similar in group 1 and 2 and significantly lower in Group 3. Malignity detection rate of group 1,2 and 3 were 28.93%, 34.89% and 55.99% respectively. Group 1 and 2 were similar (p=0.105) but 3 had more chance for cancer detection. Conclusion: Nodule is the most important finding in DRE for cancer detection. Only an asymmetric prostate itself does not mean malignity.


Subject(s)
Humans , Male , Aged , Prostate/pathology , Prostatic Neoplasms/diagnostic imaging , Prostate-Specific Antigen/blood , Digital Rectal Examination , Prostate/diagnostic imaging , Prostatic Neoplasms/pathology , Prostatic Neoplasms/blood , Retrospective Studies , Risk Factors , Ultrasonography/methods
20.
Int. braz. j. urol ; 42(3): 464-471, tab
Article in English | LILACS | ID: lil-785732

ABSTRACT

ABSTRACT Introduction The use of multi-parametric (MP) MRI to diagnose prostate cancer has been the subject of intense research, with many studies showing positive results. The purpose of our study is to better understand the accessibility, role, and perceived accuracy of MP-MRI in practice by surveying practicing urologists. Materials and Methods Surveys were sent to 7,400 practicing American Urological Association member physicians with a current email address. The survey asked demographic information and addressed access, accuracy, cost, and role of prostate MRI in clinical practice. Results Our survey elicited 276 responses. Respondents felt that limited access and prohibitive cost of MP-MRI limits its use, 72% and 59% respectively. Academic urologists ordered more MP-MRI studies per year than those in private practice (43.3% vs. 21.1%; p<0.001). Urologists who performed more than 30 prostatectomies a year were more likely to feel that an MP-MRI would change their surgical approach (37.5% vs. 19.6%, p-value=0.002). Only 25% of respondents agreed or strongly agreed that MP-MRI should be used in active surveillance. For patients with negative biopsies and elevated PSA, 39% reported MP-MRI to be very useful. Conclusions Our study found that MP-MRI use is most prominent among practitioners who are oncology fellowship-trained, practice at academic centers, and perform more than 30 prostatectomies per year. Limited access and prohibitive cost of MP-MRI may limit its utility in practice. Additionally, study participants perceive a lack of accuracy of MP-MRI, which is contrary to the recent literature.


Subject(s)
Humans , Male , Prostate/diagnostic imaging , Prostatic Neoplasms/diagnostic imaging , Practice Patterns, Physicians'/statistics & numerical data , Magnetic Resonance Imaging/economics , Magnetic Resonance Imaging/standards , Urologists/statistics & numerical data , Prostate/pathology , Prostatectomy/statistics & numerical data , Prostatic Neoplasms/pathology , United States , Biopsy , Surveys and Questionnaires
SELECTION OF CITATIONS
SEARCH DETAIL